FELLOW at King Hussein Cancer Center, Jordan.
Dr. Nabil M. S. Hasasna is a dedicated and highly trained pathologist specializing in molecular and hemato-pathology. With over a decade of progressive experience across clinical pediatrics and diagnostic pathology, he is currently serving as a Fellow in Molecular Pathology at the esteemed King Hussein Cancer Center in Amman, Jordan. Known for his cross-disciplinary approach, Dr. Hasasna blends advanced diagnostic acumen with compassionate patient care, making him a valuable asset in the modern healthcare landscape.
Profile:
🎓 Educational Background:
Dr. Hasasna holds a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dow University of Health Sciences, Karachi, where he graduated with honors. He has earned prestigious certifications including the Diplomateship of the Royal College of Pathologists (UK) and the Arab Board in Anatomic Pathology. He also completed foundational stages in both the Arab and Palestinian Boards of Pediatrics, showcasing his diverse medical training.
Professional Experience:
Dr. Hasasna’s medical journey spans multiple disciplines. He served as a Pediatric Resident in various hospitals under the Palestine Ministry of Health, gaining hands-on experience in NICU, pediatric emergency, and hemato-oncology. Later, he advanced his expertise in pathology through a rigorous residency and fellowships at King Hussein Cancer Center, where he now contributes to cutting-edge diagnostic services in molecular and hemato-pathology.
Research Intrest:
Dr. Hasasna’s primary strengths lie in clinical diagnostics and laboratory medicine, he is currently focused on molecular-level cancer diagnostics, an area rapidly evolving with personalized medicine. His fellowships in Molecular-Pathology and Hemato-Pathology offer a platform for future research initiatives, particularly in genetic profiling and targeted therapies.
Honors and Recognitions:
Dr. Nabil M. S. Hasasna has earned notable recognition for his dedication to pathology and clinical excellence. He was awarded the Diplomateship of the Royal College of Pathologists (UK) in 2021, a prestigious certification that marks international distinction in diagnostic pathology. In the same year, he completed the Arab Board in Anatomic Pathology, a rigorous credential reflecting regional expertise in tissue-based diagnostics. His continuous academic advancement, including board qualifications in both surgical pathology and pediatrics, highlights his commitment to interdisciplinary excellence. Dr. Hasasna has contributed to impactful research, with publications cited internationally, and his work has gained visibility in respected journals such as the Journal of International Medical Research and Cancers. His professional affiliations with institutions like the King Hussein Cancer Center, known for high-level cancer diagnostics and research, further validate his reputation as a rising figure in molecular and hemato-pathology. These honors collectively reflect his growing influence in the medical and research community.
Publications:
🔹 APA Format:
Hasasna, N. M. S., [Other authors]. (2025). The role of [18F]FDG PET and clinicopathologic factors in detecting and predicting bone marrow involvement in non-Hodgkin lymphoma. Cancers.
🔹 MLA Format:
Hasasna, Nabil M. S., et al. “The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.” Cancers, 2025.
🔹 Chicago Style:
Hasasna, Nabil M. S., et al. 2025. “The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma.” Cancers.
🔹 Vancouver Style:
Hasasna NMS, [Other authors]. The role of [18F]FDG PET and clinicopathologic factors in detecting and predicting bone marrow involvement in non-Hodgkin lymphoma. Cancers. 2025.